Atypical Autoantibodies in Patients with Primary Sjögren Syndrome: Clinical Characteristics and Follow-Up of 82 Cases

Seminars in Arthritis and Rheumatism

Volumn 35, Issue 5, 2006, Pages 312-321

  Ramos Casals, Manuel ^a   Nardi, Norma ^a   Brito Zerón, Pilar ^a   Aguiló, Sira ^a   Gil, Victor ^a   Delgado, German ^a   Bové, Albert ^a   Font, Josep ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

ANCA; anti DNA antibodies; anti RNP antibodies; anti Sm antibodies; anticentromere antibodies; antiphospholipid antibodies; primary Sj gren syndrome

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; DNA ANTIBODY; LUPUS ANTICOAGULANT; NEUTROPHIL CYTOPLASMIC ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; CENTROMERE; DNA; DNA TOPOISOMERASES, TYPE I; FEMALE; FOLLOW-UP STUDIES; HISTIDINE-TRNA LIGASE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SEROEPIDEMIOLOGIC STUDIES; SJOGREN'S SYNDROME;

EID: 33646489555     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2005.12.004     Document Type: Article

References (61)

1. Daniels T.E., and Fox P.C. Salivary and oral components of Sjogren's syndrome. Rheum Dis Clin North Am 18 (1992) 571-589
2. Ramos-Casals M., Tzioufas A.G., and Font J. Primary Sjogren's syndrome. new clinical and therapeutic concepts. Ann Rheum Dis 64 (2005) 347-354
3. Kassan S.S., and Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164 (2004) 1275-1284
4. Garcia-Carrasco M., Ramos-Casals M., Rosas J., Pallares L., Calvo-Alen J., Cervera R., et al. Primary Sjogren syndrome. clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81 (2002) 270-280
5. Ramos-Casals M., Font J., Garcia-Carrasco M., Brito M.P., Rosas J., Calvo-Alen J., et al. Primary Sjogren syndrome. hematologic patterns of disease expression. Medicine (Baltimore) 81 (2002) 281-292
6. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 36 (1993) 340-347
7. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome. a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 (2002) 554-558
8. Fauchais A.L., Lambert M., Launay D., Michon-Pasturel U., Queyrel V., Nguyen N., et al. Antiphospholipid antibodies in primary Sjogren's syndrome. prevalence and clinical significance in a series of 74 patients. Lupus 13 (2004) 245-248
9. Cervera R., Garcia-Carrasco M., Font J., Ramos M., Reverter J.C., Munoz F.J., et al. Antiphospholipid antibodies in primary Sjogren's syndrome. prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 15 (1997) 361-365
10. Zufferey P., Meyer O.C., Bourgeois P., Vayssairat M., and Kahn M.F. Primary Sjögren syndrome preceding systemic lupus erythematosus. a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus 4 (1995) 23-27
11. Satoh M., Yamagata H., Watanabe F., Nakayama S., Ogasawara T., Tojo T., et al. Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren's syndrome. Lupus 4 (1995) 63-65
12. Font J., Cervera R., Ramos-Casals M., Garcia-Carrasco M., Sentis J., Herrero C., et al. Clusters of clinical and immunologic features in systemic lupus erythematosus. analysis of 600 patients from a single center. Semin Arthritis Rheum 33 (2004) 217-230
13. Font J., Ramos-Casals M., Cervera R., Bosch X., Mirapeix E., García-Carrasco M., et al. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome. prevalence and clinical significance. Br J Rheumatol 37 (1998) 1287-1291
14. Ghavari A.E., Harris E.N., Asherson R.A., and Hughes G.R.V. Anticardiolipin antibodies. isotype distribution and phospholipid specificity. Ann Rheum Dis 46 (1987) 1-6
15. Brandt J.T., Barna L.K., and Triplett D.A. Laboratory identification of lupus anticoagulants. results of The Second International Workshop for identification of lupus anticoagulants. Thromb Haemost 74 (1995) 1597-1603
16. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
17. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Anonymous. Arthritis Rheum 23 (1980) 581-590
18. Bohan A., and Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 292 (1975) 344-347
19. Alarcon-Segovia D., and Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R., and Sharp G.C. (Eds). Mixed connective tissue disease and anti-nuclear antibodies (1987), Elsevier Science, Amsterdam 33-40
20. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
21. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
22. Manoussakis M.N., Gharavi A.E., Drosos A.A., Kitridou R.C., and Moutsopoulos H.M. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 44 (1987) 297-307
23. Ingram S.B., Goodnight Jr. S.H., and Bennett R.M. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies. report of two cases. Arthritis Rheum 30 (1987) 1167-1172
24. Arroyo R.A., Ridley J., Brey R.L., Houk R., Higgs J., and Boswell N. Anticardiolipin antibodies in patients with primary Sjögren's syndrome. Arthritis Rheum 32 Suppl (1989) Abstract B141
25. Pennec Y.L., Magadur G., Jouquan J., and Youinou P. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol 9 (1991) 165-167
26. Asherson R.A., Fei H.M., Staub H.L., Khamashta M.A., Hughes G.R., and Fox R.I. Antiphospholipid antibodies and HLA associations in primary Sjogren's syndrome. Ann Rheum Dis 51 (1992) 495-498
27. Jedryka-Goral A., Jagiello P., D'Cruz D.P., Maldykowa H., Khamashta M.A., Hughes G.R., et al. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren's syndrome. Ann Rheum Dis 51 (1992) 889-891
28. Biyajima S., Osada T., Daidoji H., Hisaoka T., Sakakibara Y., Tajima J., et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjogren's syndrome. Intern Med 33 (1994) 768-772
29. Merkel P.A., Chang Y., Pierangeli S.S., Convery K., Harris E.N., and Polisson R.P. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101 (1996) 576-583
30. Katayama Y., Kohriyama K., Kirizuka K., Nishizaki H., Fujii H., and Tanji Y. Sjogren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern Med 39 (2000) 73-76
31. Manoussakis M.N., Georgopoulou C., Zintzaras E., Spyropoulou M., Stavropoulou A., Skopouli F.N., et al. Sjogren's syndrome associated with systemic lupus erythematosus. clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum 50 (2004) 882-891
32. Tsuzaka K., Ogasawara T., Tojo T., Fujii H., Tsukatani Y., Kubo A., et al. Relationship between autoantibodies and clinical parameters in Sjogren's syndrome. Scand J Rheumatol 22 (1993) 1-9
33. Ohtsuka E., Nonaka S., Shingu M., Yasuda M., and Nobunaga M. Sjogren's syndrome and mixed connective tissue disease. Clin Exp Rheumatol 10 (1992) 339-344
34. Schmidt W.A., Wetzel W., Friedlander R., Lange R., Sorensen H.F., Lichey H.J., et al. Clinical and serological aspects of patients with anti-Jo-1 antibodies. an evolving spectrum of disease manifestations. Clin Rheumatol 19 (2000) 371-377
35. Gross W.L., Schmitt W.H., and Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases. a rheumatologist's perspective. Am J Kidney Dis 18 (1991) 175-179
36. Fukase S., Ohta N., Inamura K., Kimura Y., Aoyagi M., and Koike Y. Diagnostic specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in otorhinolaryngological diseases. Acta Otolaryngol Suppl 511 (1994) 204-207
37. Hiromura K., Kitahara T., Kuroiwa T., Hayashi J., Tsukada Y., Kanai H., et al. [Clinical analysis of 14 patients with anti-myeloperoxidase antibody positive rapid progressive glomerulonephritic syndrome]. Nippon Jinzo Gakkai Shi 37 (1995) 573-579
38. Hernandez J.L., Rodrigo E., De Francisco A.L., Val F., Gonzalez-Macias J., and Riancho J.A. ANCA-associated pauci-immune crescentic glomerulonephritis complicating Sjogren's syndrome. Nephrol Dial Transplant 11 (1996) 2313-2315
39. Merkel P.A., Polisson R.P., Chang Y., Skates S.J., and Niles J.L. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126 (1997) 866-873
40. Nishiya K., Chikazawa H., Hashimoto K., and Miyawaki S. Antineutrophil cytoplasmic antibody in patients with primary Sjogren's syndrome. Clin Rheumatol 18 (1999) 268-271
41. Kamachi M., Migita K., Tominaga M., Ichinose Y., Nakamura H., Origuchi T., et al. Sjogren's syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis. Nephrol Dial Transplant 14 (1999) 1033-1034
42. Tatsumi H., Tateno S., Hiki Y., and Kobayashi Y. Crescentic glomerulonephritis and primary Sjogren's syndrome. Nephron 86 (2000) 505-506
43. Akposso K., Martinant de Preneuf H., Larousserie F., Sraer J.D., and Rondeau E. [Rapidly progressive acute renal failure. A rare complication of primary Sjogren syndrome]. Presse Med 29 (2000) 1647-1649
44. Young C., Hunt S., Watkinson A., and Beynon H. Sjogren's syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3. Scand J Rheumatol 29 (2000) 267-269
45. Tubach F., Hayem G., Elias A., Nicaise P., Haim T., Kahn M.F., et al. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rhum Engl Ed 64 (1997) 362-367
46. Tektonidou M., Kaskani E., Skopouli F.N., and Moutsopoulos H.M. Microvascular abnormalities in Sjogren's syndrome. nailfold capillaroscopy. Rheumatology (Oxford) 38 (1999) 826-830
47. Caramaschi P., Biasi D., Carletto A., Manzo T., Randon M., Zeminian S., et al. Sjögren's syndrome with anticentromere antibodies. Rev Rhum (Engl Ed) 64 (1997) 785-788
48. Chan H.L., Lee Y.S., Hong H.S., and Kuo T.T. Anticentromere antibodies (ACA). clinical distribution and disease specificity. Clin Exp Dermatol 19 (1994) 298-302
49. Katano K., Kawano M., Koni I., Sugai S., and Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjogren's syndrome. J Rheumatol 28 (2001) 2238-2244
50. Isenberg D.A. Systemic lupus erythematosus and Sjogren's syndrome. historical perspective and ongoing concerns. Arthritis Rheum 50 (2004) 681-683
51. Bell D.A. SLE in the elderly-is it really SLE or systemic Sjogren's syndrome?. J Rheumatol 15 (1988) 723-724
52. Ramos-Casals M., Anaya J.M., Garcia-Carrasco M., Rosas J., Bove A., Claver G., et al. Cutaneous vasculitis in primary Sjogren syndrome. classification and clinical significance of 52 patients. Medicine (Baltimore) 83 (2004) 96-106
53. Skopouli F.N., Dafni U., Ioannidis J.P., and Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 29 (2000) 296-304
54. Theander E., Manthorpe R., and Jacobsson L.T. Mortality and causes of death in primary Sjogren's syndrome. a prospective cohort study. Arthritis Rheum 50 (2004) 1262-1269
55. Ruiz-Irastorza G., Egurbide M.V., Ugalde J., and Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 164 (2004) 77-82
56. Perez-Vazquez M.E., Villa A.R., Drenkard C., Cabiedes J., and Alarcon-Segovia D. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol 20 (1993) 437-442
57. Al Attia H.M., and D'Souza M.S. Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma. two case reports. Clin Rheumatol 22 (2003) 70-72
58. Kmieciak L., Corguille M., Rocher P., Eugene C., Lemaire E., Tennenbaum R., et al. [Autoimmune hepatitis, acute pancreatitis, mixed connective tissue disease and Sjogren's syndrome. A case report.]. Gastroenterol Clin Biol 27 (2003) 840-841
59. Brandt J., Maier T., Rudwaleit M., Kuhl U., Hiepe F., Sieper J., et al. Co-occurrence of spondyloarthropathy and connective tissue disease. development of Sjogren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis. Clin Exp Rheumatol 20 (2002) 80-84
60. Min J.K., Han N.I., Kim J.A., Lee Y.S., Cho C.S., and Kim H.Y. A case of cholestatic autoimmune hepatitis and acute liver failure. an unusual hepatic manifestation of mixed connective tissue disease and Sjogren's syndrome. J Korean Med Sci 16 (2001) 512-515
61. Radaelli F., Meucci G., Spinzi G., Terruzzi V., Imperiali G., Lenoci N., et al. Acute self-limiting jejunitis as the first manifestation of microscopic polyangiitis associated with Sjogren's disease. report of one case and review of the literature. Eur J Gastroenterol Hepatol 11 (1999) 931-934